Study | Study design | Therapy in experimental group | Therapy in control group | Sample size | Catheter type | Timing of administration | Anesthesia type | ASA score | Surgery type | |
---|---|---|---|---|---|---|---|---|---|---|
Experimental | Control | |||||||||
Agarwal et al. 2005 | RCT | Tolterodine 2 mg oral | Placebo | 50 | 165 | 16 Foley | 1 h before induction of anesthesia | General anesthesia | I/II | Urologic surgery for kidney and ureter |
Agarwal et al. 2006 | RCT | Oxybutynin 5mg / Tolterodine 2 mg oral | Placebo | 78/78 | 78 | 16 Foley | 1 h before induction of anesthesia | General anesthesia | I/II | Percutaneous nephrolithotomy surgery |
Tauzin-Fin et al. 2007 | RCT | Oxybutynin 5 mg sublingual | Placebo | 23 | 23 | 16 Foley | Every 8 h for the first 24 h after surgery | General anesthesia | I/II | Radical retropubic prostatectomy |
Ryu et al. 2013 | RCT | Butyl scopolamine 20 mg iv | Saline | 28 | 29 | 16/18 Foley | After reporting CRBD | General anesthesia | I/II | Urethrolithotomy, nephrolithotomy and radical retropubic prostatectomy |
Nam et al. 2015 | RCT | Butyl scopolamine 20 mg iv | None | 49 | 50 | 14 Foley | Intravenously immediately before the end of the operation | General anesthesia | I/II | Stomach, hepatobiliary, colorectal operation |
Chung et al. 2017 | RCT | Solifenacin 5 mg oral | None | 62 | 72 | 18 Foley | The day before, the day of, and the day after surgery | General anesthesia | NA | Transurethral resection of bladder tumor |
Srivastava et al. 2016 | RCT | Solifenacin 5 mg/Darifenacin 7.5 mg oral | Placebo | 30/30 | 30 | 16 Foley | 1 h prior to induction of anesthesia | General anesthesia | I/II | Elective spine surgery |
Sabetian et al. 2017 | RCT | Hyoscine N-butyl bromide 20 mg iv | Saline 1ml iv | 24 | 26 | 22 Foley | Intravenously before the induction of anesthesia | General anesthesia | I/II | Transurethral resection of prostate |
Maghsoudi et al. 2018 | RCT | Tolterodine 2 mg oral | Vitamin C 250 mg oral | 50 | 70 | 16 Foley | 1 h before surgery | General anesthesia | I | Percutaneous nephrolithotomy |
Kim et al. 2016 | RCT | Glycopyrrolate 0.3 mg iv | Saline 1.5 ml iv | 30 | 30 | 16 Foley | Intravenously before the induction of anesthesia | General anesthesia | I/II | Ureteroscopic removal of ureter stone |
Şahiner et al. 2020 | RCT | Atropine 15 μg/kg iv | Placebo | 30 | 30 | 16-20 Foley | The end of the surgery | General anesthesia | I/II/III | Transurethral resection |